ATE503471T1 - Mittel zur linderung von niereninsuffizienz - Google Patents

Mittel zur linderung von niereninsuffizienz

Info

Publication number
ATE503471T1
ATE503471T1 AT05809752T AT05809752T ATE503471T1 AT E503471 T1 ATE503471 T1 AT E503471T1 AT 05809752 T AT05809752 T AT 05809752T AT 05809752 T AT05809752 T AT 05809752T AT E503471 T1 ATE503471 T1 AT E503471T1
Authority
AT
Austria
Prior art keywords
agents
renal insufficiency
relieving
relieving renal
linear
Prior art date
Application number
AT05809752T
Other languages
English (en)
Inventor
Keisuke Sato
Motoaki Saito
Bang Luu
Masashi Yamada
Hiroto Suzuki
Original Assignee
Meiji Dairies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Dairies Corp filed Critical Meiji Dairies Corp
Application granted granted Critical
Publication of ATE503471T1 publication Critical patent/ATE503471T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Production Of Liquid Hydrocarbon Mixture For Refining Petroleum (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT05809752T 2004-11-25 2005-11-25 Mittel zur linderung von niereninsuffizienz ATE503471T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004341019 2004-11-25
PCT/JP2005/021705 WO2006057346A1 (ja) 2004-11-25 2005-11-25 腎機能障害改善剤

Publications (1)

Publication Number Publication Date
ATE503471T1 true ATE503471T1 (de) 2011-04-15

Family

ID=36498079

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05809752T ATE503471T1 (de) 2004-11-25 2005-11-25 Mittel zur linderung von niereninsuffizienz

Country Status (10)

Country Link
US (2) US20080125495A1 (de)
EP (1) EP1829536B1 (de)
JP (1) JP4869078B2 (de)
KR (1) KR101169633B1 (de)
CN (1) CN101065119B (de)
AT (1) ATE503471T1 (de)
CA (1) CA2589252C (de)
DE (1) DE602005027246D1 (de)
ES (1) ES2361847T3 (de)
WO (1) WO2006057346A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2609595C (en) * 2005-05-26 2013-01-08 Meiji Dairies Corporation Preventive and/or therapeutic agents for diabetic vascular disorders and respiratory disorders
JP4986505B2 (ja) * 2005-05-26 2012-07-25 株式会社明治 糖尿病性血管障害および呼吸障害予防および/または治療剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5697223A (en) 1979-12-30 1981-08-05 Takeda Chem Ind Ltd Tissue metabolism activator
AU743112B2 (en) * 1998-06-11 2002-01-17 Fox Chase Cancer Center Method for assessing a diabetic's risk of experiencing a diabetes-associated pathologic condition
JP2000083623A (ja) * 1998-09-10 2000-03-28 Nobuko Koga 食 品
JP4469441B2 (ja) * 1999-02-10 2010-05-26 明治乳業株式会社 神経変性疾患の予防又は治療薬
EP1322748B1 (de) * 2000-10-04 2009-12-02 Meiji Dairies Corporation Stemzelldifferenzierung induzierende promoter
JP4861560B2 (ja) * 2001-02-19 2012-01-25 株式会社明治 糖尿病合併症治療剤
JP3836684B2 (ja) 2001-02-19 2006-10-25 明治乳業株式会社 排尿障害治療剤
JP2004000115A (ja) * 2001-09-07 2004-01-08 Mitsuo Itakura 糖尿病の発症危険性判定方法

Also Published As

Publication number Publication date
KR20070089922A (ko) 2007-09-04
US20080125495A1 (en) 2008-05-29
ES2361847T3 (es) 2011-06-22
JP4869078B2 (ja) 2012-02-01
CA2589252A1 (en) 2006-06-01
WO2006057346A1 (ja) 2006-06-01
EP1829536B1 (de) 2011-03-30
EP1829536A4 (de) 2009-08-12
EP1829536A1 (de) 2007-09-05
DE602005027246D1 (de) 2011-05-12
CA2589252C (en) 2012-12-04
CN101065119B (zh) 2010-08-25
JPWO2006057346A1 (ja) 2008-06-05
KR101169633B1 (ko) 2012-07-31
CN101065119A (zh) 2007-10-31
US20120136068A1 (en) 2012-05-31

Similar Documents

Publication Publication Date Title
EA200870321A1 (ru) Способ получения 4-оксохинолинового соединения
EA200601830A1 (ru) Ортозамещённые арильные или гетероарильные амидные соединения
CO5640039A2 (es) Compuesto de pirazol-amida sustituidos utiles como inhibidores de cinasa
MXPA04001258A (es) Activador para el receptor d que responde al proliferador de peroxisoma.
ATE312100T1 (de) Chinuclidin-verbindungen und medikamente die diese als aktive wirkstoffe enthalten
TW200730486A (en) Organic sulfur compounds and use thereof
CY1111816T1 (el) Παραγωγο θειαδιαζολινης για την θεραπεια του καρκινου
MX2007004738A (es) Inhibidores de mif.
ATE503746T1 (de) Neue imidazolidinderivate
MY138466A (en) Aminoalkoxyndoles as 5-ht6-receptor ligands for the treatment of cns-disorders
TW200738744A (en) Anticancer agent
UA96149C2 (en) Method for producing 4-oxoquinoline compound
DE60216239T8 (de) Verwendung von Cyclohexenon-Derivaten zur Herstellung eines Arzneimittels zur Behandlung von Dysurie
ATE503471T1 (de) Mittel zur linderung von niereninsuffizienz
DK1531158T3 (da) Lipid A topisk, især kosmetisk, sammensætning, der omfatter det
MX2022002898A (es) Compuesto de 7-oxa-3,4-diazabiciclo-[4.1.0]-4-hepten-2-ona y herbicida.
EA200702290A1 (ru) Мотилидные соединения
NO20070421L (no) Radiosensitiviserende middel
DE60105618D1 (de) Dihydroporphyrinderivate und ihre verwendung
MXPA06000137A (es) Mezclas fungicidas.
TW200600013A (en) 5,6-Dialkyl-7-aminotriazolopyrimidines, their preparation and their use for controlling harmful fungi, and compositions comprising these compounds
ATE491709T1 (de) Pyrrolidinohydrochinazoline
MXPA03008725A (es) Medicamentos para hiperactividad vesicular.
EP1380299A4 (de) Mittel zur vesikalstimulation in verbindung mit prostatahypertrophie
SE0402734D0 (sv) Antimiicrobial compounds

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties